My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

2seventy bio, Inc. - Common Stock (NQ:TSVT)

5.000 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about 2seventy bio, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Earnings Scheduled For August 14, 2023 ↗

August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

Via Benzinga

Where 2seventy bio Stands With Analysts ↗

July 28, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 09, 2023

On Wednesday, 155 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 02, 2023

During Wednesday's trading, 103 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 01, 2023

On Tuesday, 46 stocks hit new 52-week lows.

Via Benzinga

2seventy bio: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

2seventy bio's Return On Capital Employed Overview ↗

March 20, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 28, 2023

Friday's session saw 59 companies set new 52-week lows.

Via Benzinga

Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls ↗

June 20, 2023

The FDA has put a clinical hold on Arcellx Inc's (NASDAQ: ACLX) iMMagine-1 Phase 2 clinical program for CART-ddBCMA investigational new drug for

Via Benzinga

Cancer Drug Trials Put On Hold After Patients Died ↗

June 17, 2023

Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including...

Via Benzinga

Wedbush Maintains Outperform Rating for 2seventy bio: Here's What You Need To Know ↗

March 17, 2023

Via Benzinga

Where 2seventy bio Stands With Analysts ↗

March 17, 2023

Via Benzinga

SVB Leerink Maintains Outperform Rating for 2seventy bio: Here's What You Need To Know ↗

January 10, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗

July 28, 2023

Via Benzinga

2seventy Bio Pauses Pediatric Blood Cancer Trial After Patient Death, Stock Plunges ↗

June 14, 2023

2seventy Bio Inc (NASDAQ: TSVT) announced that the Phase 1 trial of the PLAT-08 study of SC-DARIC33 in Acute Myeloid Leukemia (AML), has been paused by Seattle Children's, the company's partner and...

Via Benzinga

2seventy Bio Stock Crumbles After A Patient Dies In Its Pediatric Cancer Study ↗

June 14, 2023

The company is investigating whether the death is tied to the experimental drug.

Via Investor's Business Daily

Expert Ratings for 2seventy bio ↗

January 10, 2023

Via Benzinga

Week in Review: VectorBuilder Raises $57 Million for Gene Therapy Delivery CDMO ↗

October 30, 2022

Via Talk Markets

Benzinga Pro's Top 5 Stocks To Watch For Friday, May 12, 2023: CMCSA, KR, ON, TSVT, CMND ↗

May 12, 2023

Comcast (CMCSA) - The parent company of NBCUniversal. One of Friday's most-discussed stories stemmed from a tweet by Elon Musk he had found a new exec to file the chief exec role at Twitter.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 24, 2023

On Monday, 147 stocks made new 52-week lows.

Via Benzinga

Legend Biotech Breaks Out After Leaked Documents Show Big CAR-T Benefit ↗

April 19, 2023

The company could have the best-in-class CAR-T drug for multiple myeloma patients.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Friday ↗

April 21, 2023

During Friday's session, 149 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 28, 2023

Via Benzinga

Bristol Myers-2seventy Partnered Abecma Cuts Risk Of Disease Progression, Death By 51% In Pretreated Myeloma Patients ↗

February 10, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 22, 2022

Thursday's session saw 329 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

December 20, 2022

On Tuesday, 298 companies achieved new lows for the year.

Via Benzinga

4 Analysts Have This to Say About 2seventy bio ↗

November 08, 2022

Over the past 3 months, 4 analysts have published their opinion on 2seventy bio (NASDAQ:TSVT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022 ↗

October 31, 2022

Upgrades

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 10, 2022

Via Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.